velaglucerase alfa sold brand name vpriv medication used treatment gaucher disease type hydrolytic lysosomal glucocerebrosidespecific enzyme recombinant form glucocerebrosidase identical amino acid sequence naturally occurring manufactured shire plc common side effects include abdominal belly pain headache dizziness bone pain arthralgia joint pain back pain infusionrelated reactions asthenia weakness fatigue tiredness pyrexia fever increased body velaglucerase alfa approved medical use united states february european union august velaglucerase alfa indicated longterm enzymereplacement therapy ert people gaucher drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikivelaglucerasealfa